Vetter bids farewell to Managing Director Thomas Otto as he retires

Thomas Otto concludes his 35 successful years in the family business by stepping down as managing director. © Vetter Pharma International GmbH

– Over 35 years at Vetter, including 23 years in management
– Remains with the company in an advisory role
– Transition to an experienced leadership team strategically planned early

After more than 35 years at Vetter, including 23 years as Managing Director, Thomas Otto is stepping down from his management position at the turn of the year. With his clear leadership and great commitment, he has significantly shaped the sustainable development and continuous growth of Vetter, an important partner of global pharmaceutical companies for the manufacturing of life-improving medicines. Even in challenging times, he successfully and confidently led the company together with his colleagues in management.

“Thomas Otto has decisively advanced our family business with foresight, innovation, and a strong sense of responsibility. His contribution to the development and internationalization of Vetter is outstanding and deserves the highest recognition,” emphasizes Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the founding family. “For more than three decades, he has been a reliable shaper, initiator, and bridge-builder – both within the company and outwardly. On behalf of the Vetter family and the company advisory board, I thank him for his extraordinary commitment and the sustainable influence on our success story.”

Thomas Otto summarizes: “I am grateful for the many years at Vetter and proud of what we have achieved together. I am especially pleased that I could contribute to positioning the company strongly and sustainably for the future. I wish my colleagues in management continued success and am confident that they will continue to develop Vetter with competence and passion.”

Forward-looking succession planning

The new leadership of Vetter was planned early and strategically: Already at the beginning of 2025, the three long-standing and experienced Vetter executives Henryk Badack, Titus Ottinger, and Carsten Press were appointed to the management board. With their profound understanding of the company, its customers, and the industry, they significantly contribute to a sustainable future for the company and continue the trusting collaboration with the founding family and the advisory board.

For customers, employees, partners, and the region, Vetter remains reliable: The globally active pharmaceutical service provider continues to stand for quality and stability, strong partnerships, and sustainable development. In close cooperation with its customers, the company contributes to ensuring that life-improving medicines are reliably available to help patients worldwide achieve a higher quality of life.

Thomas Otto will remain with the company in an advisory capacity. He will bring his extensive knowledge and decades of experience with pharmaceutical construction projects to the planned development of a new production site in Germany.